Clinical Trial: Discrimination of N2a and N2b by EBUS-TBNA: is a Change of the Needle Necessary?

U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07418450) titled 'Discrimination of N2a and N2b by EBUS-TBNA: is a Change of the Needle Necessary?' on Feb. 10.

Brief Summary: During EBUS staging in patients with mediastinal lymphadenopathy, it is planned to perform a first round of staging with change of the needle between all lymph nodes and a second round of staging without change of the needle.

Study Start Date: Nov. 05, 2025

Study Type: INTERVENTIONAL

Condition: Lung Cancer (Diagnosis)

Intervention: DIAGNOSTIC_TEST: EBUS-TBNA

During EBUS staging, the needle well be changed between all lymph node stations in a first round. The EBUS staging will be repeated without the change of the needl...